Objective. The surgical treatment of extensive diffuse pigmented villonodular synovitis (PVNS) of large joints alone is unsatisfactory, with high rates of local recurrence. Postsynovectomy adjuvant treatment with external beam radiation therapy or intra-articular injection of yttrium 90 ( 90 Y) yielded better results. We report our experience with 10 cases treated with debulking surgery followed by intra-articular injection of 90 Y. Patients and methods. Between January 1989 and June 1998, 10 patients (eight males and two females aged 15-49 yr) with extensive diffuse PVNS were treated. In six patients the knee joint, in three patients the ankle joint, and in one patient the hip joint were involved. The 10 patients underwent 15 operations, one patient had three surgical procedures, and three patients underwent two surgeries (the intervals between re-operations for local recurrence were 2-4 yr). All patients had an intra-articular injection of 15-25 mCi 90 Y, 6-8 weeks after the last surgery.
PVNS is a benign proliferative histiocytic disorder of the synovium. In 1941, Jaffe described it as a group of synovial, tenosynovial and bursal lesions w1x. Localized and diffuse forms of synovial involvement were reported w2x. PVNS affects people in their third or fourth decades of life w3x. In most cases the disease is monoarticular and involves mainly the knee joint; the hip and ankle joints follow in frequency w3x. The lesion is rarely polyarticular w4, 5x; it has the potential to invade extensively local structures such as muscles, tendons, bones and skin w6x.
PVNS should be included in the differential diagnosis when arthritis with or without a mass presents in a single major joint in young people. Joint aspiration reveals a brownish discolouration of the fluid due to the breakdown of blood products (haemosiderin) within the joint w7x.
The classical appearance of PVNS on plain X-ray films is of a soft-tissue swelling or mass about the joint, with joint-space preservation. No peri-articular osteoporosis is seen w3, 8, 9x. Erosions or subchondral cysts are common, and are more prevalent when PVNS occurs at 'tight' joints, such as the hip, ankle or elbow, than in the knee w3x. No intra-articular calcifications are seen. Osteophytes are rare. The effusion may appear dense on plain X-ray films or CT scan due to the high iron content. MRI will show the effusion, and the haemosiderin-laden soft tissue masses will be seen as areas of low signal intensity on T 1 , and especially on T 2 sequences. This is more pronounced on gradient echo than on spin-echo images. The size of the region of abnormal tissue may appear larger than the real lesion ('blooming' phenomenon) due to the magnetic susceptibility effect caused by haemosiderin w8x.
Pathologically, the lesion shows dense infiltrate of polygonal or spindle cells with abundant cytoplasm and vesicular nuclei; some of the cells contain haemosiderin. Multinucleated giant cells are sometimes present, either scarcely or in large numbers. Aggregation of foamy cells can also be seen. Abundant production of collagen, fibrosis and hyalinization may be evident in patients with long-standing disease w10x (Fig. 1) .
The pathogenesis of PVNS is not clear, however most authors believe it is caused by chronic inflammation w11x. Others think it is a neoplastic disorder, such as a giant cell sarcoma arising near or inside the synovial space or tendon sheath. The latter theory is supported by monoclonality and chromosomal abnormalities w12-14x. Disturbances of metabolism, trauma and haemorrhage are other possible aetiologies.
Complete excision of the mass in the affected joint is the treatment of choice in the localized form w10x. In extensive diffuse cases total synovectomy is needed, but to carry out this procedure with 'acceptable' joint damage is difficult, and in many cases almost impossible to achieve w10x. This is the reason that other treatment modalities such as radiation and intra-articular injection of 90 Y have been tried and shown to be effective in reducing the rate of local recurrence with 'acceptable' joint damage w15, 16x. The main long-term goal is to avoid the need for joint replacement in young people.
In few publications,
90
Y was injected into the joint of diffuse or recurrent PVNS with good results w15, 17x. We report our experience in 10 cases treated by surgical debulking (subtotal synovectomy) followed by intra-articular 90 Y.
Patients and methods
Between January 1989 and June 1998 (9.5 yr), 10 patients with extensive diffuse biopsy-proven PVNS of a major joint were treated ( Six patients underwent one surgical procedure, three patients underwent two surgical procedures (one recurrence; patients 3, 9 and 10) and one patient underwent three surgical procedures (two recurrences; patient 8). These four patients (3, 8, 9 and 10) were presented to us as a local recurrence after previous surgeries elsewhere. The intervals between surgeries were 2-4 yr, as reported by them. All of them received an intra-articular injection of 15-25 mCi (555-925 MBq) 90 Y (Amersham, UK) 6-8 weeks after last surgery (Fig. 4) . The dose of injected 90 Y depends on the volume of the joint and body size. The functional and radiological status of the affected joints before last surgery and intra-articular injection of 90 Y were diffuse swelling and pains, with a range of motion that was reduced by approximately 25-50%. All patients used analgesic and non-steroidal anti-inflammatory drugs on a regular basis. In all cases, except for that of patient 5, only mild osteoarthritic changes were noted on plain X-ray radiographs. 90 Y is a beta emission colloid with a physical halflife of 64 h and a beta radiation of 2.27 MeV w18x. The maximal penetration in the synovium and cartilage is 11 and 8.5 mm, respectively w18x.
The procedure was performed in the operating room. Under aseptic conditions, a needle was inserted into the affected joint and the fluid was aspirated. An arthrogram was performed in order to ensure the location of the needle and the integrity of the joint space, and only then was 90 Y injected. Passive movements of the joint were performed on the table to ensure spreading of 90 Y in the joint space. A Geiger counter, which was located around the affected joint, was used throughout the procedure to ensure no systemic leakage of 90 Y. A bulky dressing was placed over the joint for 48-72 h. Gradual movement of the joint and limb weight bearing were advocated after the first 3-4 days.
The patients were checked every month for the first 3-4 months using clinical joint examination for pain, tenderness, range of motion and plain X-ray films. After that, a semi-annual follow-up examination with the same protocol was performed. CT or MRI was performed 6 months after the injection and then once a year.
Results
In none of our patients was systemic leakage of 90 Y observed during the procedure. In nine patients, no evidence of local recurrence and no progressive bone anduor joint destruction were noted on clinical and imaging studies. No follow-up biopsies or arthroscopies were performed as it was simple to follow these patients with clinical examinations, plain X-rays, and CT and MRI in particular (see Patients and methods). In one 
Discussion
This series is small, with a regular distribution of ages and affected joints, but it includes only extensive diffuse PVNS of these joints in young patients. The final common pathway of this disease leads to total joint destruction, which eventually leads to the need for joint replacement w20x. This should be avoided if possible, especially in these young and healthy patients.
The traditional effective treatment for PVNS is surgical synovectomy w20x. It can be done either by arthroscopy or by arthrotomy. Arthroscopic synovectomy has reduced morbidity and is well tolerated by patients w21x. Open surgical synovectomy causes stiffness, pain and has a long recovery time, mainly after procedures involving the knee joint. Arthroscopic surgery, especially in diffuse cases, has a high recurrence rate in comparison to open synovectomy, which is still high in itself w10x. Although Flandry reported a recurrence rate of <10% in open surgical knee synovectomy over 5 yr of follow-up, in most papers the recurrence rate is between 25 and 45% w4x.
Another solution should be considered if synovectomy alone might create more than reasonable damage or if the disease recurs. In either of these cases, two adjuvant treatments are available: the first is low dose radiotherapy and the second is intra-articular injection of 90 Y. Both methods have shown good results w15-17x. Radiation therapy is usually applied for malignant tumours as a definitive or adjuvant treatment. Radiation therapy for non-malignant conditions is infrequently used. This method of treatment has been suggested for PVNS following partial resection, where salvage of subsequent recurrence may compromise function w16x.
There are few publications that deal with low-dose external beam radiation therapy for treatment of diffuse PVNS w10, 16x. The technique involves treatment of the entire circumference of the limb at joint level with ;3000-4000 rad w16x. Most of these patients show improvement, although the average follow-up time is unclear. No long-term radiotherapy complications have been described. However, the long-term effects of radiation on soft tissues, bones or joints, including the risk of secondary cancer, are well known w22x. Since PVNS is still a benign disorder, the use of even low-dose radiotherapy should be considered with caution.
Approximately 40 patients who received intra-articular injection of 90 Y for PVNS have been described in six articles, the most recent of which was published in 1992 w15, 17, 23-26x. Most patients showed clinical improvement, which correlated in some publications to the timing of 90 Y injection, relative to the number of recurrences after previous surgical synovectomies. The results were better when 90 Y was used earlier. The side effects of intra-articular injection of 90 Y are few, predictable and avoidable w26x. These include radionecrosis of the extraarticular soft tissues, febrile and local painful reactions, and leakage of radioactivity from the affected joint to the entire body via the lymph nodes w27x. The first two side effects are minor and easily treatable. Radionecrosis of the surrounding soft tissues rarely occurs if needle placement is confirmed by fluoroscopy and an arthrogram. Needle tract necrosis can be eliminated by flushing the needle with saline prior to removal. Febrile and painful reactions are usually mild, temporary and easily managed with antipyretic and analgetic drugs.
Systemic leakage of radioactivity theoretically has the potential to cause infertility w28x. With respect to 90 Y treatment for persistent synovitis or arthritis, with which many more patients were treated, there was no evidence of a cause and effect relationship between it and infertility w22x. None of those patients treated with intraarticular 90 Y injection developed infertility. Franssen measured the systemic leakage of radioactivity outside eight knees 48 h after injection of 90 Y w15x. Count rates were measured above the knee joint, the inguinal nodes, the liver and the heart, and were expressed as a percentage of the amount of radioactivity in the injected knee joint. The results showed that only 1% of 90 Y diffused outside the knee.
A theoretical problem is the risk of secondary malignant changes resulting from the treatment of a benign disease. Chromosomal damage to circulating lymphocytes is reported to occur following injection of intra-articular 90 Y w29x. The degree of damage closely reflected the comparative uptake of the isotope in regional lymph nodes 24 h after intra-articular injection. The risk of secondary malignant changes would be greater if the chromosomal damage in these patients were a true index of whole-body irradiation, and would suggest a possible increased incidence of leukaemia and solid neoplasms. In this situation the chromosomal changes do not represent a whole-body irradiation, but rather a selective irradiation of some lymphocytes in the regional lymph nodes w29x. Dolphin calculated that if 5 mCi of 90 Y are distributed evenly throughout the body, the total body irradiation would be 13 rad, and the risk of cancer induction following such a dose would be 0.4 per 1000 patients treated w30x.
Among the small number of patients who were treated with 90 Y for PVNS and the larger number of patients who were treated for chronic synovitis or arthritis, none developed cancer. The long-term effects of 90 Y on the articular cartilage were considered, but review of the available literature (as performed) did not disclose any mention of such an effect until now. In our series (six out of 10 patients were <35 yr of age), no complications of any of the above mentioned types occurred. Treatment using 90 Y in teenagers and young adults, especially young women, is still under discussion in some quarters, where radiation therapy for non-malignant pathology is controversial. One of our patients was a 15 yr-old adolescent male, but with closed physes. We had two females in our series, the younger of whom was 35 yr old. No complications have yet occurred in this patient subgroup.
None of the reviewed articles compared low-dose radiotherapy with intra-articular injection of 90 Y for PVNS. Moreover, the number of patients who were treated using each method was small, and hence no firm conclusions can be drawn.
We combined 90 Y injection and a traditional open synovectomy, albeit a limited one, by performing debulking, leaving behind a microscopic amount of disease to be treated with intra-articular 90 Y. In this way we avoided the disadvantages of complete total synovectomy and the long-term hazards of external beam radiation therapy in such difficult cases.
Conclusion
In conclusion it seems that in selected patients with primary or recurrent extensive diffuse PVNS, the combination of debulking surgery followed by intraarticular 90 Y is a good and safe solution as a joint-saving procedure. Larger series with long-term follow-up results are needed in order to compare the available methods of treatment.
